Cilostazol Cilostazol, a 2-oxo-quinoline, is a potent, reversible type 3 phosphodiesterase inhibitor, targeting both platelets and vascular smooth muscle cells.

When cilostazol, a representative PDE3 inhibitor, was added to the growth medium of metatarsal bone cultures, the researchers observed a significant increase in bone outgrowth when compared to control ...

Defining the fine balance between ischemic and bleeding risk remains a challenge in stented patients undergoing surgery treated with antiplatelet therapy. Understanding whether an antithrombotic drug ...

New research has revealed that a type of drug commonly used to treat heart disease, asthma and thrombosis, also stimulates bone growth – suggesting that these drugs could be repurposed for treating ...